This is consistent with a previous report which has demonstrated that LXR/ApoE axis represses MDSCs viability in dependent of LRP8, thereby activating CD8+ T cells and facilitating anti-tumor immunity [18]. This evidence concerns the gene LRP8 and neoplasm.